Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP542186.RAi_Iijj3IXOllkBg9V20ZmakFStsFlPLuN_UUrrKKtTw130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542186.RAi_Iijj3IXOllkBg9V20ZmakFStsFlPLuN_UUrrKKtTw130_provenance.
• NP926470.RAabpz8ef8_-M_1NSOElQAWt1jmRRIMuRCTrOOV9t9zP0130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926470.RAabpz8ef8_-M_1NSOElQAWt1jmRRIMuRCTrOOV9t9zP0130_provenance.
• NP661050.RAXl1nLkfYFAZJGdQJg5_0CXM8A_iDB8G7tzFh8c0kUfI130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661050.RAXl1nLkfYFAZJGdQJg5_0CXM8A_iDB8G7tzFh8c0kUfI130_provenance.
• NP641380.RAp0zcIjlIFFeFJMdOy7ftJx51S0pYEFWcAtdveWXiN4A130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641380.RAp0zcIjlIFFeFJMdOy7ftJx51S0pYEFWcAtdveWXiN4A130_provenance.
• NP410558.RALAWrJcc_wWq7jFSQwLYPrvjrjv1IQZbBQ5cRzXpW2Dk130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410558.RALAWrJcc_wWq7jFSQwLYPrvjrjv1IQZbBQ5cRzXpW2Dk130_provenance.
• NP515894.RADVzKCefcPD3xfPxIX_ACu_zKxSOw_JY1sfYyLEFQehk130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515894.RADVzKCefcPD3xfPxIX_ACu_zKxSOw_JY1sfYyLEFQehk130_provenance.
• NP553337.RAHOVkg9ZhP8fD9DzXiJtrYroSTbueO6yE_zqu_JguV3E130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553337.RAHOVkg9ZhP8fD9DzXiJtrYroSTbueO6yE_zqu_JguV3E130_provenance.
• NP493606.RASr8iF9bRT5qlGT2OYtnBdYcqBqdYfp9Q9wNRTM4GXM0130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493606.RASr8iF9bRT5qlGT2OYtnBdYcqBqdYfp9Q9wNRTM4GXM0130_provenance.
• NP583942.RAf8S8q3m4WERUxyE9VY9JI0koAJnOchh2__37dIVXYa4130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583942.RAf8S8q3m4WERUxyE9VY9JI0koAJnOchh2__37dIVXYa4130_provenance.
• NP583944.RAS-Et30a8g5F6gaN52bAVlwicN82jUlnwk9xrUe-cFIQ130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583944.RAS-Et30a8g5F6gaN52bAVlwicN82jUlnwk9xrUe-cFIQ130_provenance.
• assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP493532.RApwJe1Rq7DOeb1hV4E0J0ebAGBrl-F7AX1mbFLzIZ3Dk130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493532.RApwJe1Rq7DOeb1hV4E0J0ebAGBrl-F7AX1mbFLzIZ3Dk130_provenance.
• NP583940.RAHtM-cIPJf3Ybpxnynx11BmH1OBvAsvZwrr5mWdxZwDo130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583940.RAHtM-cIPJf3Ybpxnynx11BmH1OBvAsvZwrr5mWdxZwDo130_provenance.
• NP583943.RAgz2iDD3WIE7OPI6S2NJJ0ii5mKbxhWeW6M6qMC9omXA130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583943.RAgz2iDD3WIE7OPI6S2NJJ0ii5mKbxhWeW6M6qMC9omXA130_provenance.
• NP515830.RAoUm6vU3AZ1uYc0TPJm_O7MY9Gx82I47So4VHAY1mYYw130_assertion description "[Moreover, in mice, intrasplenic injection of IDO+ leukemia/ lymphoma A20 cells induces the expansion of bona fide T(reg) cells by conversion of CD4+CD25- T cells; this effect is counteracted by 1-MT treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515830.RAoUm6vU3AZ1uYc0TPJm_O7MY9Gx82I47So4VHAY1mYYw130_provenance.